Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2000
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000046196A1 Indole derivatives and their use as mcp-1 antagonists
08/10/2000WO2000046195A1 Anti-inflammatory indole derivatives
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045834A2 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
08/10/2000WO2000045821A1 Analgesic agent tetralgin and method for preparing the same
08/10/2000WO2000045816A1 Calcilytic compounds
08/10/2000WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO2000045796A1 Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000WO2000033824A3 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
08/10/2000WO2000028975A3 Improved chemical process and pharmaceutical formulation
08/10/2000WO2000027372A8 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000010545A3 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000CA2362401A1 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361589A1 Calcilytic compounds
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2361066A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/10/2000CA2356898A1 Indole derivatives and their use as mcp-1 antagonists
08/10/2000CA2355734A1 Indole derivatives as anti-inflammation agents
08/09/2000EP1025238A2 Death associated kinase containing ankyrin repeats (dakar)
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025079A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
08/09/2000EP1024835A1 J-chain and analogues as epithelial cell targeting conjugates
08/09/2000EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/09/2000EP1024808A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
08/09/2000EP1024807A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
08/09/2000EP1024802A1 (3$i(R),4$i(R))-$g(D)-TETRAHYDROCANNABINOL-11-OIC ACIDS USEFUL AS ANTIINFLAMMATORY AGENTS AND ANALGESICS
08/09/2000EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
08/09/2000EP0642519B1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000EP0568645B1 Mixed specificity fusion proteins
08/09/2000CN1262685A Naphthyridine derivatives
08/09/2000CN1262684A 2,4,4-trisubstituted-1,3-dioxolane antifungals
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
08/09/2000CN1262624A Use of colchinol derivatives as vascular damaging agents
08/09/2000CN1055245C Medicated plaster for treating lumbago
08/09/2000CN1055240C Medicinal composition for relieving inflammatory pain of local soft tissue and its preparing process
08/08/2000US6100387 Chimeric polypeptides containing chemokine domains
08/08/2000US6100377 Aromatically adjusted and confined amino acid sequences; for the development of more efficient synthetic polypeptides
08/08/2000US6100299 Tumor necrosis factor inhibitor; anticarcinogenic agents, antiinflammatory agents
08/08/2000US6100290 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
08/08/2000US6100284 Antiallergens
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100264 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their preparation, their intermediates and medicaments containing them
08/08/2000US6100259 Cannabinoid receptor modulators
08/08/2000US6100258 Aromatic amine compounds that antagonize the pain enhancing effects of prostaglandins
08/08/2000US6100246 Spiro-piperidine derivatives as inhibitors of nitric oxide synthase
08/08/2000US6100235 Methods of treating immune and inflammatory response with IL-17 receptors
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000US6099836 Treatment of reperfusion injury
08/08/2000US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/08/2000CA2185019C Isoxazoline compounds as inhibitors of tnf release
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
08/03/2000WO2000044790A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044756A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
1 ... 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 ... 1272